UFSP2
Ufm1-specific protease 2
Also known as: C4orf20, FLJ11200, UFSP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NUQ7
- Gene
- UFSP2
- Ensembl
- ENSG00000109775
- Chromosome
- 4
- Canonical length
- 469 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a highly conserved cysteine protease. The protein cleaves two C-terminal residues from ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein. Activation of ubiquitin-fold modifier 1 by the encoded protein exposes a C-terminal glycine residue that allows interaction with other proteins and transfer to its target protein. An allelic variant of this gene has been associated with Beukes hip dysplasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
469 residues, UniProt reviewed canonical sequence.
>Q9NUQ7|UFSP2
1 MVISESMDIL FRIRGGLDLA FQLATPNEIF LKKALKHVLS DLSTKLSSNA LVFRICHSSV
61 YIWPSSDINT IPGELTDASA CKNILRFIQF EPEEDIKRKF MRKKDKKLSD MHQIVNIDLM
121 LEMSTSLAAV TPIIERESGG HHYVNMTLPV DAVISVAPEE TWGKVRKLLV DAIHNQLTDM
181 EKCILKYMKG TSIVVPEPLH FLLPGKKNLV TISYPSGIPD GQLQAYRKEL HDLFNLPHDR
241 PYFKRSNAYH FPDEPYKDGY IRNPHTYLNP PNMETGMIYV VQGIYGYHHY MQDRIDDNGW
301 GCAYRSLQTI CSWFKHQGYT ERSIPTHREI QQALVDAGDK PATFVGSRQW IGSIEVQLVL
361 NQLIGITSKI LFVSQGSEIA SQGRELANHF QSEGTPVMIG GGVLAHTILG VAWNEITGQI
421 KFLILDPHYT GAEDLQVILE KGWCGWKGPD FWNKDAYYNL CLPQRPNMILocalizationUniProt · AlphaFold · HPA
Whether an antibody against UFSP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- retina: 52 nTPM
- choroid plexus: 46 nTPM
- skeletal muscle: 46 nTPM
- tongue: 38 nTPM
- kidney: 35 nTPM
- heart muscle: 30 nTPM
Single-cell type
- late primary spermatocytes: 264 nCPM
- epicardial cells: 214 nCPM
- early spermatids: 154 nCPM
- oocytes: 124 nCPM
- rod photoreceptor cells: 94 nCPM
- müller glia: 81 nCPM
Immune cell
- MAIT T-cell: 26 nTPM
- memory CD8 T-cell: 24 nTPM
- naive CD4 T-cell: 23 nTPM
- naive CD8 T-cell: 23 nTPM
- memory B-cell: 22 nTPM
- memory CD4 T-cell: 22 nTPM
Brain region
- choroid plexus: 39 nTPM
- cerebellum: 29 nTPM
- white matter: 28 nTPM
- hypothalamus: 23 nTPM
- basal ganglia: 21 nTPM
- thalamus: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about UFSP2.
Disease | AllUniProt
Conditions UFSP2 is implicated in, by any mechanism.
- Beukes hip dysplasia (HDB) MIM:142669
- Spondyloepimetaphyseal dysplasia, Di Rocco type (SEMDDR) MIM:617974
- Developmental and epileptic encephalopathy 106 (DEE106) MIM:620028
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 117 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spondyloepimetaphyseal dysplasia, di rocco type
- Hip dysplasia, Beukes type
- Developmental and epileptic encephalopathy 106
- Cerebral visual impairment and intellectual disability
- Developmental dysplasia of the hip
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of proteolysis involved in protein catabolic process
- proteolysis
- regulation of intracellular estrogen receptor signaling pathway
- regulation of type II interferon production
- rescue of stalled ribosome
- ribosome disassembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- UFSP1/2/DUB, catalytic domain
- Peptidase family C78
- UFSP2, second domain
- Ubiquitin-fold modifier 1 specific protease 2, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UFSP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UFSP2 as an antibody target. Whether an autoantibody or antibody against UFSP2 could matter depends on whether native UFSP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UFSP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UFSP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...